Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 9/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.52 |
| ▸ | STS | P08842 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11179500 | 0.83 | LMNA (0.65) | ELANESRD5A2HPGDRAB9ACES2 | |
| SCHEMBL8154525 | 0.82 | CA1 (0.59) | ALDH1A1SRD5A2SMN1; SMN2NPC1HPGD | |
| SCHEMBL15609863 | 0.78 | MAPT (0.61) | ALDH1A1STSGAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL50261 | 0.78 | CES2 (0.77) | ELANEALDH1A1GAAL3MBTL1HTT | |
| SCHEMBL6618691 | 0.78 | CES2 (0.77) | ELANEALDH1A1GAAL3MBTL1HTT | |
| Benzophenone SCHEMBL27935236 | 0.78 | CES2 (0.77) | ELANEALDH1A1GAAL3MBTL1HTT | |
| SCHEMBL9419497 | 0.77 | SRD5A2 (0.80) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL124917 | 0.77 | SRD5A2 (0.80) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL28938440 | 0.77 | SRD5A2 (0.80) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL9809047 | 0.77 | SRD5A2 (0.80) | ELANEALDH1A1SRD5A2STSGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10939684-B2 | Preparation of sulfonamide-containing antimicrobials and substrate treating compositions of sulfonamide-containing antimicrobials | NANO SAFE COATINGS INCORPORATED (US) | 2021-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10939684-B2 | Preparation of sulfonamide-containing antimicrobials and substrate treating compositions of sulfonamide-containing antimicrobials | MSR1, RPS4Y1, MRPS35 | ELANE 707/4885ALDH1A1 3336/4885SRD5A2 1290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.